Acurx Pharmaceuticals shares are trading lower by 30% during Friday’s session. The company announced a $1.1 million registered direct offering.
Why Acurx Pharmaceuticals (ACXP) Shares Are Down 30%
More from STOCKMore posts in STOCK »
- Will Argentina Lose Its Oil Giant? How a U.S. Judge’s Decision Could Change Everything
- What Does Mark Zuckerberg’s New Meta Superintelligence Labs Mean for You? Discover the Future of AI Here!
- Will AI Automation Make Your Job Obsolete? Learn What the Amazon CEO Predicts!
- Is China’s Manufacturing Sector Surging? What June’s Data Reveals About Economic Gains.
- How Can Open-Source Models and Cloud Computing Propel Sovereign AI Development? Experts Weigh In!
Comments are closed.